ArticleResearch square2025
Exploring facilitators and barriers to early TB case finding at private community pharmacies in Kampala, Uganda using the Consolidated Framework for Implementation Research (CFIR).
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Background: Tuberculosis (TB) remains one of the leading global infectious diseases killer, with Uganda among the countries bearing the highest TB/HIV burden. The World Health Organization's (WHO) ambitious End TB strategy by 2030 emphasizes the strong involvement of private healthcare providers in TB efforts. In line with this, Uganda has adopted the WHO's public-private mix (PPM) model. This study explored the facilitators and barriers to engaging private community pharmacies in the early detection of TB cases in Kampala, Uganda. Design/Methods: We conducted a qualitative study at five private community pharmacies in Kampala. We used in-depth interviews with healthcare providers (HCPs) dispensing medications at private community pharmacies, pharmacy clients, and key informant interviews with pharmacy owners/managers. Data was analyzed using an inductive thematic approach, identifying themes as barriers or facilitators to engaging private community pharmacies in TB case finding. These themes were then mapped to the Consolidated Framework for Implementation Research (CFIR) domains and constructs. Results: Facilitators of TB screening at private community pharmacies include: pharmacy staff's willingness to be trained and collaborate with healthcare professionals to screen for TB. Healthcare providers acknowledge TB as a serious public health threat and view community pharmacies as valuable partners in early detection and prevention. Leveraging existing community awareness and targeted communication campaigns can further enhance patient engagement in TB screening services.The barriers identified include limited space and the high facility expansion costs, inadequate access to TB screening tools and equipment, and persistent stigma and public misconceptions about TB that may deter patients from seeking screening. Pharmacy staff also face knowledge gaps, resource constraints, and potential revenue losses from referring patients to hospitals. Conclusions: These findings provide a basis for designing contextually appropriate interventions targeting factors that are likely to promote the engagement of private community pharmacies in Uganda in early TB case findings. Future studies should assess the impact of addressing identified barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.